Author: Jazaeri Farsani, Seyed Mohammad; Oude Munnink, Bas B.; Canuti, Marta; Deijs, Martin; Cotten, Matthew; Jebbink, Maarten F.; Verhoeven, Joost; Kellam, Paul; Loens, Katherine; Goossens, Herman; Ieven, Margareta; van der Hoek, Lia
Title: Identification of a Novel Human Rhinovirus C Type by Antibody Capture VIDISCA-454 Cord-id: 19z5n0hv Document date: 2015_1_19
ID: 19z5n0hv
Snippet: Causative agents for more than 30 percent of respiratory infections remain unidentified, suggesting that unknown respiratory pathogens might be involved. In this study, antibody capture VIDISCA-454 (virus discovery cDNA-AFLP combined with Roche 454 high-throughput sequencing) resulted in the discovery of a novel type of rhinovirus C (RV-C). The virus has an RNA genome of at least 7054 nt and carries the characteristics of rhinovirus C species. The gene encoding viral protein 1, which is used for
Document: Causative agents for more than 30 percent of respiratory infections remain unidentified, suggesting that unknown respiratory pathogens might be involved. In this study, antibody capture VIDISCA-454 (virus discovery cDNA-AFLP combined with Roche 454 high-throughput sequencing) resulted in the discovery of a novel type of rhinovirus C (RV-C). The virus has an RNA genome of at least 7054 nt and carries the characteristics of rhinovirus C species. The gene encoding viral protein 1, which is used for typing, has only 81% nucleotide sequence identity with the closest known RV-C type, and, therefore, the virus represents the first member of a novel type, named RV-C54.
Search related documents:
Co phrase search for related documents- accession number and acute phase: 1
- acid isolation and acute phase: 1
- acid position and low identity: 1, 2
Co phrase search for related documents, hyperlinks ordered by date